US Patent Issued to The University of Chicago, The Board of Trustees of the University of Illinois on Aug. 26 for "Cancer treatment with 237 CAR-T cell based therapeutics recognizing the Tn epitope" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,192, issued on Aug. 26, was assigned to The University of Chicago (Chicago) and The Board of Trustees of the University of Illinois (Urbana, Ill.).

"Cancer treatment with 237 CAR-T cell based therapeutics recognizing the Tn epitope" was invented by Hans Schreiber (Chicago), David Kranz (Champaign, Ill.), Karin Schreiber (Chicago), Yanran He (Chicago) and Preeti Sharma (Urbana, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides Tn epitope-specific chimeric antigen receptors and scFvs, including soluble scFvs and multimeric scFvs, as well as methods of identifying cancer subjects and cancer subject sub-populations amenable to ...